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l-Asparaginases catalyse the hydrolysis of asparagine to aspartic acid and
ammonia. In addition, l-asparaginase is involved in the biosynthesis of amino
acids such as lysine, methionine and threonine. These enzymes have been used
as chemotherapeutic agents for the treatment of acute lymphoblastic leukaemia
and other haematopoietic malignancies since the tumour cells cannot synthesize
sufﬁcient l-asparagine and are thus killed by deprivation of this amino acid.
l-Asparaginases are also used in the food industry and have potential in the
development of biosensors, for example for asparagine levels in leukaemia. The
thermostable type I l-asparaginase from Thermococcus kodakarensis (TkA) is
composed of 328 amino acids and forms homodimers in solution, with the
highest catalytic activity being observed at pH 9.5 and 85C. It has a Km value of
5.5 mM for l-asparagine, with no glutaminase activity being observed. The
crystal structure of TkA has been determined at 2.18 A˚ resolution, conﬁrming
the presence of two / domains connected by a short linker region. The
N-terminal domain contains a highly ﬂexible -hairpin which adopts ‘open’ and
‘closed’ conformations in different subunits of the solved TkA structure. In
previously solved l-asparaginase structures this -hairpin was only visible when
in the ‘closed’ conformation, whilst it is characterized with good electron density
in all of the subunits of the TkA structure. A phosphate anion resides at the
active site, which is formed by residues from both of the neighbouring
monomers in the dimer. The high thermostability of TkA is attributed to the
high arginine and salt-bridge content when compared with related mesophilic
enzymes.
1. Introduction
l-Asparaginase (EC 3.5.1.1) catalyses the hydrolysis of
asparagine to aspartic acid and ammonia and has a range of
biological roles. For instance, plants transport nitrogen in the
form of l-asparagine from their roots to growing tissues and
thus have a high demand for this enzyme (Sieciechowicz et al.,
1988; Atkins et al., 1975). In bacteria, when amino acids
become the primary carbon source in anaerobic conditions,
the expression level of asparaginase can be increased by 100-
fold (Cedar & Schwartz, 1967, 1968). This is important since
the metabolites of asparagine (and glutamine) can feed into
the citric acid cycle. In contrast, the preferred carbon source,
glucose, is a catabolite repressor of asparaginase expression.
Thus, asparaginases and glutaminases are necessary for cell
growth in ammonia-deﬁcient media and their expression is
activated by the presence of these amino acids in the medium.
Many asparaginases also have activity towards glutamine,
producing glutamic acid, and can be classiﬁed accordingly.
Type I enzymes are cytosolic and have a low glutaminase
activity of around 2–10% of the l-asparagine hydrolysis
ISSN 2059-7983
# 2017 International Union of Crystallography
electronic reprint
activity. In contrast, type II enzymes are usually periplasmic
and have comparable l-asparaginase and l-glutaminase
activities (Boyd & Phillips, 1971; Chohan & Rashid, 2013;
Davidson et al., 1977). Type I and type II l-asparaginases have
low sequence similarity; for example, those from Escherichia
coli have a sequence identity of only 24%. Generally, the
enzymes form dimers or tetramers (dimers of dimers) with a
subunit molecular mass of 35 kDa.
In humans, l-asparaginase has been widely used as a
chemotherapeutic agent for the treatment of acute lympho-
blastic leukaemia (ALL) and other haematopoietic malig-
nancies. ALL is the most common childhood acute leukaemia,
constituting approximately 80% of childhood leukaemias and
20% of adult leukaemias (Fullmer et al., 2010). The history of
asparaginase usage for the treatment of ALL can be traced
back to the 1950s, when Kidd spotted that the progression of
murine lymphoma was reduced by guinea-pig serum (Kidd,
1953). This discovery attracted broad interest and it was found
that only guinea-pig serum had anti-lymphoma activity, in
contrast to the sera of other animals such as horse or rabbit.
In the 1960s, Broome identiﬁed that it was the l-asparaginase
in guinea-pig serum which contributed mainly to the anti-
lymphoma activity (Broome, 1961, 1963). Treatment with
l-asparaginase has been shown to have improved event-free
survival for ALL from <10% to >80% in recent years
(Silverman et al., 2001; Pui et al., 2009; Mo¨ricke et al., 2008).
Cancer cells, such as lymphatic cells, have a high demand for
asparagine for their survival and proliferation (Kiriyama et al.,
1989; Stams et al., 2003). However, owing to the lack of
l-asparagine synthetase required for l-asparagine synthesis,
leukaemic lymphoblasts and some other tumour cells can only
obtain this amino acid from blood serum. l-Asparaginase
hydrolyses asparagine in the serum, leading tumours to a state
of cell death (apoptosis), while healthy cells are not affected
because they possess sufﬁcient l-asparagine synthetase. In
addition, studies have shown that l-asparaginase inhibits the
mTOR pathway and induces an autophagic process which
contributes to its anti-leukaemic activity and greatly affects
leukaemia cells (Song et al., 2015). Unlike conventional cancer
therapy, l-asparaginase treatment is highly discriminatory.
Only the type II l-asparaginases from E. coli (EcAII) and
Erwinia chrysanthemi (ErAII) have been approved for the
treatment of ALL. The E. coli enzyme shows a higher activity,
whilst the E. chrysanthemi enzyme has been used to treat
patients who are allergic to the former (Albertsen et al., 2001).
In the USA, the most commonly used form of l-asparaginase
is a covalent conjugation with polyethylene glycol, since
PEGylation improves the bioavailability and biostability and
reduces the immunological response. The elimination half-life
of PEG-asparaginase (6 d) is ﬁve times longer than native
EcAII preparations and nine times longer than ErAII
preparations. This is an important improvement since the
enzyme shows peak activity in the ﬁfth day after intramuscular
injection (Shrivastava et al., 2016). In Europe, it is currently a
second-line treatment only for patients who are allergic to
native asparaginases. Side effects of l-asparaginase therapy
such as immune responses, allergies and anaphylactic shock
(Soares et al., 2002) may be attributed to several reasons,
including its l-glutaminase activity, which reduces the plasma
l-glutamine level (Avramis et al., 2002; Villa et al., 1986). Thus,
looking for alternative sources of l-asparaginase with fewer or
no side effects is of great importance.
The enzyme is also widely applied in the food industry since
treatment with l-asparaginase prior to cooking signiﬁcantly
reduces the formation of acrylamide. Acrylamide, also known
as 2-propenamide, is a colourless and odourless crystalline
solid that has potent neurotoxicity. It is largely produced from
heat-induced reactions, e.g. frying or baking starchy foods at
over 120C, and is formed between the -amino group of
asparagine and the carbonyl group of reducing sugars such as
glucose (Friedman, 2003).
l-Asparaginase has been used to develop biosensors for the
analysis of asparagine levels in leukaemia and in the food
industry. Hydrolysis of asparagine produces ammonium ions,
which induce a pH change that can be monitored spectro-
photometrically using a suitable dye (Kumar et al., 2013).
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Figure 1
The reaction catalysed by l-asparaginase. The reaction involves nucleophilic attack on the asparagine side chain by one of the two active-site threonine
residues, generating a -acyl enzyme intermediate which is then hydrolysed to release the product.
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The mechanism of l-asparaginase catalysis involves an
intermediate known as a -acyl-enzyme (Fig. 1), which is
formed by the action of one of the catalytic threonine residues
(Thr11 and Thr85 in TkA) nucleophilically attacking the side-
chain amide C atom of the substrate l-asparagine. This is
followed by nucleophilic attack on the intermediate by an
enzyme-bound water molecule, which releases the product
l-aspartate (Verma et al., 2007).
The type I thermostable l-asparaginase from Thermococcus
kodakarensis (TkA) is composed of 328 amino acids with a
molecular mass of 35.5 kDa (Chohan & Rashid, 2013). Gel
ﬁltration demonstrated that the enzyme is active as a homo-
dimer in solution, with the highest activity being observed at
pH 9.5 and 85C. It has aKm value of 5.5 mM for l-asparagine,
while no glutaminase activity was observed. In addition, TkA
exhibited d-asparaginase activity, which was about 50% of the
l-asparaginase activity. Here, we report the crystal structure
analysis of TkA, which has been performed at a resolution of
2.18 A˚.
2. Methods
Recombinant TkA was expressed and puriﬁed according to
the method described by Chohan & Rashid (2013). In essence,
the TK1656 gene was ampliﬁed by PCR and cloned into
the pET-21a vector for expression in E. coli BL21-Codon-
Plus(DE3)-RIL cells. Puriﬁcation involved heat treatment at
80C for 20 min followed by the use of a Resource Q column
(GE Healthcare) running a 0–1M NaCl gradient. The puriﬁed
enzyme was stored in 20 mM Tris–HCl pH 8.0. Screening for
crystallization conditions was conducted using the sitting-drop
method with a Mosquito robot. Crystals were obtained at a
protein concentration of 10 mg ml1 in MORPHEUS condi-
tion C6; for details, see Gorrec (2009). Optimum conditions
were later found to be 0.03M of each of NaNO3, Na2HPO4
and (NH4)2SO4, 0.1M sodium HEPES/MOPS pH 7.5, 20%
ethylene glycol, 10% PEG 8000 at 21C. Selected crystals were
transferred to a 10 ml drop containing 50% Paratone N
MD2-08 and 50% parafﬁn oil to remove the mother liquor
surrounding the crystals before ﬂash-cooling and data collec-
tion.
X-ray data collection was carried out remotely at station I03
of Diamond Light Source (DLS) at 100 K using a PILATUS3
6M detector. Automatic data processing using xia2 (Winter,
2010) indicated that all of the crystals were triclinic and
belonged to space group P1. Since this is an uncommon space
group, other possibilities were checked by integration of the
raw diffraction images with DIALS (Waterman et al., 2013)
and scaling with AIMLESS (Evans & Murshudov, 2013),
which also suggested that P1 was the most likely symmetry.
The best crystal diffracted to 2.18 A˚ resolution and the data
were of good quality, as suggested by phenix.xtriage (Zwart et
al., 2005). Analysis using MATTHEWS_COEF (Kantardjieff
& Rupp, 2003; Matthews, 1968) suggested that this crystal
form possesses six monomers per asymmetric unit, with a
solvent content of 47.32%.
The structure was determined by molecular replacement
with Phaser MR (McCoy et al., 2007) using the type I
l-asparaginase from Pyrococcus horikoshii (PhA; PDB entry
1wls; 59% sequence identity to TkA; Yao et al., 2005) as the
search model. The structure-factor correlation coefﬁcient was
approximately 40% for the ﬁrst correctly positioned monomer
and it increased by a few percent for each monomer that was
added to the structural model. Manual rebuilding and
correction were accomplished using Coot (Emsley et al., 2010)
followed by TLS, local NCS and restrained reﬁnement by the
use of REFMAC5 (Murshudov et al., 1997, 2011). The struc-
ture was then submitted to the PDB_REDO website (Joosten
et al., 2014) for further reﬁnement and validation. Model
validation was also performed using MolProbity (Chen et al.,
2010). All of the statistics for data collection, data processing,
structure determination and reﬁnement are shown in Table 1.
The VADAR (Willard et al., 2003) and ESBRI (Costantini et
al., 2008) online services were used to analyse hydrogen bonds,
salt bridges and other factors related to the thermostability of
the enzyme. The ﬁgures were prepared using MarvinSketch
(ChemAxon), PyMOL (Schro¨dinger) and CueMol (http://
www.cuemol.org).
3. Results and discussion
3.1. Quality of the model
The electron density for the ﬁrst ﬁve chains (A, B, C, D and
E) is of good quality, whilst that for chain F suggests that this
monomer is slightly more disordered than the others since a
number of regions have poor electron density. Indeed, the ﬁrst
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Table 1
X-ray statistics for the TkA structure.











Resolution (A˚) 68.65–2.18 (2.26–2.18)
Rmerge (%) 6.3 (121.9)
Rmeas (%) 7.5 (143.4)
CC1/2 (%) 99.8 (58.8)
Completeness (%) 97.4 (97.2)
Average I/(I) 10.1 (1.3)
Multiplicity 3.5 (3.6)
No. of observed reﬂections 342457 (35236)
No. of unique reﬂections 98478 (9841)
Wilson plot B factor (A˚2) 50.0
Solvent content (%) 47.3
R factor (%) 19.8
Rfree (%) 22.6
R.m.s.d., bond lengths (A˚) 0.017
R.m.s.d., bond angles () 2.01
No. of reﬂections in working set 98,475
No. of reﬂections in test set 4,894
Mean protein B factor (A˚2) 47.7
PDB identiﬁer 5ot0
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four chains are characterized by all-atom average B factors of
around 43.6 A˚2, while chains E and F have higher B factors of
53.3 and 59.3 A˚2, respectively. Data analysis suggested that the
data were of good quality and that no anisotropy or transla-
tional NCS was present. Analysis byMolProbity indicated that
95.5% of the residues are in the Ramachandran favoured
region, with an additional 1.0% being classed as outliers.
3.2. Overall structure
The six chains in the asymmetric unit of TkA share a very
similar structure, with r.m.s.d. values ranging from 0.08 to
0.15 A˚ for the C atoms. When considering chain A only, the
r.m.s.d. values between TkA and the E. coli type I and II
l-asparaginases are 1.11 and 1.67 A˚, respectively. Thus, TkA
has a similar overall fold to both classes of l-asparaginase.
Each subunit of TkA consists of an N-terminal and a
C-terminal / domain connected by a linker loop formed by
residues 185–203 (Fig. 2). The N-terminal domain contains
an eight-stranded mixed -sheet (1, 4–8, 11 and 12)
ﬂanked by four -helices (1–4). It has been shown that the
-hairpin composed of strands 2 and 3 is highly ﬂexible and
is often characterized by poor or no electron density. This
-hairpin is involved in substrate binding and catalysis, and
adopts ‘open’ and ‘closed’ conformations (Nguyen et al.,
2016). However, this often disordered area is characterized by
good electron density in all of the subunits of TkA. Chains B
and D show a more ‘open’ conformation compared with EcA
(PDB entry 2p2d; Yun et al., 2007), whilst the other chains
adopt a more ‘closed’ conformation, leaving this region of the
E. coli enzyme somewhere between them (Fig. 3). Of greater
signiﬁcance is the fact that the 1 helix has moved towards the
active site in all of the subunits. The 4 helix has also moved
slightly towards the active site. Thus, it is very likely that these
two helical segments participate in substrate recognition in
addition to the ﬂexible -hairpin. Part of the main sheet is
formed by a pronounced -hairpin, involving 9 and 10,
which resides between the two domains of the enzyme and
participates in subunit adhesion within the physiological
dimer. The active site of TkA is located in a pocket in which
the two catalytically important threonine residues, Thr11 and
Thr85, occur and consists of residues from the two neigh-
bouring monomers of the dimer.
The relatively small C-terminal domain is formed mainly by
a three-stranded parallel -sheet (13–15) and ﬁve -helices
(5–9). There is also a putative allosteric site which is located
between the 15 strand and the 8 helix (Fig. 2) and is
involved in asparagine binding (Yun et al., 2007), giving rise to
a cooperative conformational switch from an inactive to an
active form of the enzyme.
The sequence alignment of TkAwith several homologues is
shown in Fig. 4. TkA shares 58.3 and 60.6% sequence identity
over all residues with the l-asparaginase from P. furiosus
(PfA) and an l-asparaginase I homologue from P. horikoshii
(PhA), respectively. In contrast, it has sequence identities of
below 30% with EcA, EcAII and ErAII. However, there are
many highly conserved regions in all of these proteins,
including the active site, which suggests that they are likely to
share a similar tertiary structure and catalytic mechanism.
3.3. Active site
As mentioned before, TkA is active as a homodimer and
many residues from both subunits are involved in substrate
recognition and catalysis. Structural comparison identiﬁed
Thr11, Tyr21, Ser54, Thr55, Thr85, Asp86 and Lys156, as well
as Tyr2330 and Glu2750 from the neighbouring subunit, as
being both important and highly conserved in l-asparaginases
(Figs. 3 and 4). One of the two key residues participating in
catalysis, Thr11, resides in a -hairpin whose ﬂexibility is
considered to be deeply involved in the activity of the enzyme.
The other key residue, Thr85, which is located in the loop
between 3 and 5, mediates sequential ‘ping-pong’ nucleo-
philic attacks together with Thr11 during amidohydrolysis
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Figure 2
The overall structure of TkA. Each monomer is composed of an
N-terminal and a C-terminal domain connected by a loop (coloured
grey). The two key threonine residues involved in catalysis are shown in
ball-and-stick representation. The active site and the putative allosteric
site are indicated by a red star and a green asterisk, respectively.
Figure 3
Structural superposition of TkA with the E. coli type I l-asparaginase.
The structures are in approximately the same orientation as that shown in
Fig. 2. Chains A and B of TkA and both subunits of the E. coli enzyme
(PDB entry 2p2d) are coloured red, yellow and blue, respectively. The
arrows indicate the segments which adopt different conformations in
response to substrate binding.
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(Harms et al., 1991). Since some unexpected electron density
was identiﬁed in the active site of each monomer, many
different molecules were ﬁtted in an effort to identify it,
including the substrate asparagine and the product aspartic
acid. However, this feature was ﬁnally interpreted and
successfully reﬁned as a phosphate ion. This was one of the
components of the crystallization buffer and has been
reported in other asparaginase structures (Tomar et al., 2014;
Wehner et al., 1992). The phosphate anion occupies the
binding site for the substrate and forms many interactions with
the side chains of the neighbouring residues, including Thr11
and Thr85. Tomar et al. (2014) also suggested that the binding
of a ligand (asparagine, citrate or phosphate) stabilizes the
ﬂexible -hairpin, which acts as a gatekeeper and prevents
further substrate entry. However, Yun et al. (2007) reported
that this hairpin is still not visible in the Asp- or Asn-bound
structures. In addition, the B and D chains in the TkA enzyme
adopt a more ‘open’ conformation than that of the ligand-free
E. coli type I l-asparaginase
(PDB entry 2p2d).
Yun et al. (2007) indicated that
l-asparaginases which have high
l-glutaminase activity possess
smaller residues at the equivalent
position to residue Gly2370 in
TkA. They predicted that those
with a glycine at this position
should have substantial glut-
aminase activity. However, whilst
TkA does possess a glycine at this
position, no glutaminase activity
has been observed.
3.4. Thermostability
The great thermostability of
hyperthermophilic proteins can
be attributed to several factors.
These proteins tend to have
greater hydrophobicity (Haney et
al., 1997), more hydrogen bonds
(Vogt et al., 1997; Vogt & Argos,
1997) and salt bridges (Yip et al.,
1995, 1998; Haney et al., 1997;
Kumar, Ma et al., 2000), increased
helical content, low occurrence of
thermolabile residues such as Cys
and Ser (Russell et al., 1997), high
occurrence of Arg, Tyr and Pro
(Watanabe et al., 1997; Bogin et
al., 1998; Haney et al., 1997),
amino-acid substitutions within
and outside the secondary struc-
tures (Zuber, 1988; Haney et al.,
1997; Russell et al., 1997), better
packing, smaller and less
numerous cavities, deletion or
shortening of loops (Russell et al.,
1997), increased surface area
buried upon oligomerization
(Salminen et al., 1996) and
increased polar surface area
(Haney et al., 1997; Vogt et al.,
1997; Vogt & Argos, 1997).
However, it should be noted that
no single factor proposed to
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Figure 4
A sequence alignment showing the secondary-structure characteristics of TkA. Helices and strands are
labelled according to the TkA structure. All of the conserved residues are boxed and the fully conserved
residues are coloured white with a red background, while the less conserved residues are coloured red. The
alignment was performed using ESPript 3.0 (Robert & Gouet, 2014).
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contribute towards protein thermostability is 100% consistent
in all thermophilic proteins. Kumar, Tsai et al. (2000) observed
that the most consistent trend is shown by side chain–side
chain hydrogen bonds and salt bridges. They may rigidify a
thermophilic protein in the room-temperature range and the
protein may still be ﬂexible enough at high temperature in
order to function (Jaenicke & Bo¨hm, 1998).
A comparison of some of these factors for several
thermophilic and mesophilic l-asparaginases is shown in Table
2, and those which probably contribute to the thermostability
of the TkA dimer are indicated in bold. The increased content
of salt bridges and arginine residues along with the lower
number of Cys and Ser residues are notable features of TkA.
The monomer–monomer contacts in the dimer are pre-
dominantly mediated by the C-terminal domains of each
subunit, which form a continuous -sheet involving strands
13–15 of both monomers (Fig. 5). The occurrence of
signiﬁcantly higher than average B factors in the outer-facing
helical segments of the C-terminal domains of the dimer
formed by the last two monomers in the asymmetric unit
(chains E and F) suggests that the dimerization interface of
the protein may have greater ﬂexibility at higher tempera-
tures, perhaps leaving the structure of the catalytic domains in
the dimer relatively unaffected.
4. Summary
The crystal structure of TkA has been determined at 2.18 A˚
resolution in space group P1 with six monomers in the
asymmetric unit, forming three dimeric pairs. Each subunit of
TkA consists of an N-terminal and a C-terminal / domain
connected by a linker loop. TkA is active as a homodimer and
many residues from the neighbouring molecules in a dimer are
involved in substrate recognition as well as in catalysis. The
N-terminal domain contains a highly ﬂexible -hairpin which
adopts ‘open’ and ‘closed’ conformations in different subunits
of the TkA structure. This region is usually only visible in
l-asparaginase structures that adopt a ‘closed’ conformation,
whilst it is characterized with good electron density in all of
the subunits in the TkA structure. One phosphate anion has
been built in the active site. The great thermostability of TkA
may be attributed to the higher arginine content, the lower
numbers of Cys and Ser residues and the increased content of
salt bridges.
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